Implementing Brief Tobacco Cessation Interventions in Community Pharmacies: An Application of Rogers' Diffusion of Innovations Theory.
brief intervention
community pharmacy
pharmacist
quitline
smoking
smoking cessation
tobacco
tobacco cessation
Journal
Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532
Informations de publication
Date de publication:
30 May 2022
30 May 2022
Historique:
received:
18
04
2022
revised:
18
05
2022
accepted:
25
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Pharmacists, as highly accessible members of the healthcare team, have considerable potential to address tobacco use among patients. However, while published data suggest that pharmacists are effective in helping patients quit, barriers exist to routine implementation of cessation services in community pharmacy settings. Within the context of a randomized trial (n = 64 pharmacies), surveys were administered over a period of 6 months to assess pharmacists' perceptions of factors associated with the implementation of "Ask-Advise-Refer", a brief intervention approach that facilitates patient referrals to the tobacco quitline. Study measures, grounded in Rogers' Diffusion of Innovations Theory, assessed pharmacists' perceptions of implementation facilitators and barriers, perceptions of intervention materials provided, and perceived efforts and personal success in implementing Ask-Advise-Refer at 6-months follow-up. Findings indicate that while the brief intervention approach was not difficult to understand or implement, integration into normal workflows presents greater challenges and is associated with overall confidence and implementation success. Lack of time was the most significant barrier to routine implementation. Most (90.6%) believed that community pharmacies should be active in promoting tobacco quitlines. Study results can inform future development of systems-based approaches that lead to broad-scale adoption of brief interventions, including but not limited to tobacco cessation, in pharmacy settings.
Identifiants
pubmed: 35736771
pii: pharmacy10030056
doi: 10.3390/pharmacy10030056
pmc: PMC9230644
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R01 CA 129312
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA129312
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA 117865
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA117865
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA236637
Pays : United States
Références
J Am Pharm Assoc (2003). 2014 Jan-Feb;54(1):42-4
pubmed: 24407740
PLoS One. 2017 Aug 16;12(8):e0183172
pubmed: 28813473
J Clin Pharm Ther. 2014 Jun;39(3):240-7
pubmed: 24749899
Patient Educ Couns. 2006 Apr;61(1):152-60
pubmed: 16533683
Cochrane Database Syst Rev. 2019 Oct 31;2019(10):
pubmed: 31684695
Prev Med. 2005 Jun;40(6):888-95
pubmed: 15850892
J Am Pharm Assoc (2003). 2012 Jul-Aug;52(4):507-14
pubmed: 22825231
BMC Med. 2016 Dec 16;14(1):209
pubmed: 27978837
Nicotine Tob Res. 2011 Feb;13(2):135-45
pubmed: 21196451
Ann Pharmacother. 2010 Sep;44(9):1395-402
pubmed: 20628045
J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):9-16
pubmed: 20097634
J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):387-394
pubmed: 29779983
Arch Intern Med. 2010 Oct 11;170(18):1640-6
pubmed: 20937922
Int J Pharm Pract. 2009 Aug;17(4):221-9
pubmed: 20161528
Arch Intern Med. 2010 Oct 11;170(18):1646-7
pubmed: 20937923
J Emerg Nurs. 2018 May;44(3):242-248
pubmed: 28864084
Am J Pharm Educ. 2013 Jun 12;77(5):93
pubmed: 23788804
Res Social Adm Pharm. 2013 Jul-Aug;9(4):396-404
pubmed: 22841641
Pharmacotherapy. 2003 May;23(5):666-73
pubmed: 12741442
J Contin Educ Health Prof. 2011 Fall;31 Suppl 1:S60-6
pubmed: 22190102
Health Technol Assess. 2015 Nov;19(95):1-156
pubmed: 26565129
Pharmacotherapy. 2007 Jul;27(7):1040-51
pubmed: 17594210
Nicotine Tob Res. 2018 Nov 15;20(12):1418-1426
pubmed: 29059419
Am J Pharm Educ. 2007 Dec 15;71(6):109
pubmed: 19503693
Res Social Adm Pharm. 2017 Sep - Oct;13(5):889-891
pubmed: 28619650
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
J Am Pharm Assoc (2003). 2018 May - Jun;58(3):253-257
pubmed: 29426612
Res Social Adm Pharm. 2013 Jan-Feb;9(1):27-36
pubmed: 22554394
Am J Med Qual. 2015 Mar-Apr;30(2):135-40
pubmed: 24500644
J Subst Abuse Treat. 2019 Apr;99:163-170
pubmed: 30797390
Res Social Adm Pharm. 2022 Jul;18(7):3158-3163
pubmed: 34544660